Medicine, Rheumatology Division

Grants

Grants per year 1993 2002 2007 2008 2010 2011 2013 2014 2015 2016 2017 2018 2019 2020 2021 2027

• 1 Not started
• 76 Active
• 356 Finished

Grants per year

Search results

• Prot# C0168T34: The Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) Protocol -- Tapering Methotrexate in Patients with Rheumatoid Arthritis Beginning Therapy with Infliximab

  Ruderman, E. M.

  Kendle International Inc., Centocor, Inc.

  4/15/02 → 5/24/07

  Project: Research project

• Prot# 016.0040: Open-Label, Long-Term Extension Study of Etanercept in the Treatment of Patients with Ankylosing Spondylitis Who Participated in Protocol 016.0037

  Ruderman, E. M.

  Immunex Corporation

  7/1/02 → 9/13/10

  Project: Research project

• Strength, Laxity, and Position Sense in OA Progression

  Sharma, L. & Dunlop, D. D.

  National Institute of Arthritis and Musculoskeletal and Skin Diseases

  8/1/02 → 7/31/07

  Project: Research project

  • disability 100%
  • applicant 66%
  • infrastructure 50%
  • costs 40%
  • history 38%

• CAREER: Northwestern University Mentored Scholars Program

  Greenland, P., Chang, R. W., Jain, M., Ramsey-Goldman, R., Varga, J., Chang, R. W., Dunaif, A. E., Emanuel, L. L., Hauser, J. M., Jain, M., Majka, D. S., Ramsey-Goldman, R., Schnaper, H. W. & Sznajder, J. I.

  National Center for Research Resources

  9/1/02 → 7/31/08

  Project: Research project

  • recipient 100%
  • mentoring 53%
  • cadre 33%
  • applicant 27%
  • didactics 27%

• Prot# N49-02-12-202: REVISED Protocol for a Double-Blind, Placebo-Controlled, Randomized Comparison of the Efficacy and Safety of Celecoxib 200mg and Celecoxib 400mg QD in Treating the Signs and Symptoms of Psoriatic Arthritis

  Ruderman, E. M.

  Pharmacia & Upjohn, Inc.

  9/24/02 → 5/21/07

  Project: Research project

• Genetic Risk Profile in Longitudinal SLE Cohorts

  Ramsey-Goldman, R.

  University of Alabama at Birmingham, National Institute of Arthritis and Musculoskeletal and Skin Diseases

  9/24/02 → 8/31/07

  Project: Research project

• Laxity and Malalignment in a Large Cohort Study of OA

  Sharma, L. & Dunlop, D. D.

  National Institute of Child Health and Human Development

  9/26/02 → 8/31/09

  Project: Research project

  • Knee 100%
  • Multicenter Studies 93%
  • Cohort Studies 48%
  • Reading 31%
  • Cartilage 31%

• Chicago Initiative to Raise Asthma Health Equity

  Grammer III, L. C., Weiss, K. B., Chang, C., Dunlop, D. D., Grammer III, L. C., Peters, A. T., Saltoun, C. A. & Wolf, M.

  National Heart, Lung, and Blood Institute

  9/30/02 → 7/31/08

  Project: Research project

  • Asthma 100%
  • Health Equity 99%
  • African Americans 25%
  • County Hospitals 18%
  • Mentors 16%

• Prot# 061-00/COX523: A Randomized, Double-Blind, Multicenter Study to Evaluate the Tolerability and Effectiveness of Etoricoxib 90 mg q.d. vs. Diclofenac Sodium 50 mg t.I.d. in Patients with Osteoarthritis

  Ruderman, E. M.

  Merck & Co., Inc.

  10/18/02 → 10/18/05

  Project: Research project

• Prot# 016.0035: Rheumatoid Arthritis DMARD Intervention and Utilization Study (RADIUS 2)

  Ruderman, E. M.

  Immunex Corporation

  10/29/02 → 12/1/07

  Project: Research project

• The Role of Mcl-1 in the Macrophages and RA

  Pope, R. M. & Perlman, H. R.

  National Institute of Arthritis and Musculoskeletal and Skin Diseases

  1/1/03 → 12/31/08

  Project: Research project

  • Macrophages 100%
  • Phosphatidylinositol 3-Kinases 40%
  • Experimental Arthritis 32%
  • Fibroblasts 30%
  • Preliminary Data 29%

• Prot# IM101-031-016: A Phase III, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Clinical Use Study to Evaluate the Safety and Tolerability of BMS-188667 Administered Intravenously to Subjects with Active RA with or without Medic

  Ruderman, E. M.

  Bristol-Myers Squibb Pharmaceutical Research Institute

  1/9/03 → 9/11/10

  Project: Research project

• Osteoporosis Brochure Highlighting Therapeutic Options for Lupus Patients and Treating Physicians

  Ramsey-Goldman, R.

  Procter & Gamble Company

  1/24/03 → 12/31/03

  Project: Research project

• Prot# GL02-01: A Randomized, Double-Blind, Multi-Center, Placebo Controlled Study to Assess Prevention of Bone Loss by Treatment with Gl701 (Prestara?) in Women with Systemic Lupus Erythematosus Receiving Treatment with Glucocorticoids

  Ramsey-Goldman, R.

  Genelabs Technologies, Inc.

  1/31/03 → 8/21/10

  Project: Research project

• CAREER: Chemokine Receptor Antagonists in Inflammatory Disease

  Pope, R. M.

  National Institute of Arthritis and Musculoskeletal and Skin Diseases

  2/1/03 → 7/31/08

  Project: Research project

  • Chemokine Receptors 100%
  • CC Chemokines 86%
  • Rheumatoid Arthritis 42%
  • Atherosclerosis 27%
  • Cytokines 26%

• Prot# 120-20: A Randomized, Placebo-Controlled, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Rituximab in Combination with Methotrexate in Patients with Active Rheumatoid Arthritis Who Have Had an Inadequeate Respo

  Ruderman, E. M.

  IDEC Pharmaceuticals Corporation

  5/6/03 → 9/10/10

  Project: Research project

• Prot# M02-518: A Phase III Multicenter Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab (D2E7) in Subjects with Moderate to Severely Active Psoriatic Arthritis

  Ruderman, E. M.

  PPD Development, Abbott Laboratories

  5/7/03 → 9/10/10

  Project: Research project

• Role of Flip Macrophages

  Pope, R. M. & Thimmapaya, B.

  National Institute of Arthritis and Musculoskeletal and Skin Diseases

  7/1/03 → 6/30/09

  Project: Research project

  • Toll-Like Receptor 1 100%
  • Macrophages 67%
  • Rheumatoid Arthritis 66%
  • Fas Ligand Protein 58%
  • NF-kappa B 51%

• Prot# WA17043/U2644g: A Randomized, Multifactorial, Double-Blind, Parallel-Group, Dose-Ranging Study of the Efficacy and Safety of Rituximab (Mabthera®/Rituxan®) In Combination with Methotrexate in Patients with Active Rheumatoid Arthritis

  Ruderman, E. M.

  Genentech, Inc.

  7/11/03 → 6/1/07

  Project: Research project

• Chronic Prostatitis Collaborative Research Network

  Schaeffer, A. J., Nadler, R. B. & Pope, R. M.

  National Institute of Diabetes and Digestive and Kidney Diseases

  9/5/03 → 2/28/09

  Project: Research project

  • Prostatitis 100%
  • Pelvic Pain 61%
  • Placebos 54%
  • Prunus africana 50%
  • Chronic Pain 47%

• Prot# M02-537: A Multi-Center Continuation Trial for Patients Completing Study M02-518 and M02-570 of the Human Anti-TNF Monoclonal Antibody Adalimumab (D2E7) in Patients with Moderate to Severely Active Psoriatic Arthritis

  Ruderman, E. M.

  PPD Development, Abbott Laboratories

  9/24/03 → 9/11/10

  Project: Research project

• Rheumatoid Arthritis Associated Autoimmunity in a High Risk Adult Population

  Majka, D. S.

  Arthritis Foundation

  10/1/03 → 9/30/05

  Project: Research project

• Prot# LBSL02: A Phs 2, Mlti-Cntr, Dbl-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety, Tolerability, & Efficacy of LymphoStat-B? Antibody (Monoclonal Anti-BLyS Antibody) in Subjects w/Systemic Lupus Erythematosus (SLE)

  Ramsey-Goldman, R.

  Human Genome Sciences, Inc.

  11/14/03 → 8/21/10

  Project: Research project

• Functional Limitation, Arthritis, Depression, and Race

  Dunlop, D. D. & Chang, R. W.

  National Institute of Arthritis and Musculoskeletal and Skin Diseases

  12/1/03 → 11/30/07

  Project: Research project

  • functional impairment 100%
  • medical rehabilitation 67%
  • health 63%
  • retirement 44%
  • skin disease 36%

• Prot# LBRA01: A Phase 2, Multi-Center, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety, Tolerability, and Efficacy of LymphoStat-B? Antibody (Monoclonal Anti-BLyS Antibody) in Subjects with Rheumatoid Arthritis (RA)

  Ruderman, E. M.

  Human Genome Sciences, Inc.

  1/15/04 → 5/24/07

  Project: Research project